Skip to main content
SpringerLink
Log in

Ein potenzieller neuer Standard für die Darmkrebstherapie?

Neoadjuvante Chemotherapie beim operablen Kolonkarzinom

  • Journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Morton D et al. J Clin Oncol. 2023;41(8):1541-52

  2. Li Y et al. Int J Biol Sci. 2016;12(8):1022-31

  3. Dossa F et al. Lancet Gastroenterol Hepatol. 2017;2(7):501-13

  4. Schrag D et al. N Engl J Med. 2023;389(4):322-34

  5. Sargent DJ et al. J Clin Oncol. 2010;28(20):3219-26

  6. www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Kolorektales_Karzinom/Version_2/LL_KRK_Langversion_2.1.pdf(abgerufen am 7. Februar 2024)

  7. Kanani A et al. Br J Surg. 2021;108(12):1417-25

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Jena, Bachstraße 18, 07743, Jena, Germany

    Georg W. Wurschi

Authors
  1. Georg W. Wurschi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georg W. Wurschi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wurschi, G. Neoadjuvante Chemotherapie beim operablen Kolonkarzinom. Gastro-News 11, 16–17 (2024). https://doi.org/10.1007/s15036-024-3681-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-024-3681-0

Search

Navigation